These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 433766)

  • 1. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.
    Rothman MT
    Br Med J; 1980 Mar; 280(6218):922-3. PubMed ID: 7388371
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH; Kennelly BM
    S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine effects due to disopyramide.
    Frieden J
    N Engl J Med; 1978 Apr; 298(17):975. PubMed ID: 642984
    [No Abstract]   [Full Text] [Related]  

  • 6. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D
    Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G; Seipel L; Haerten K
    Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some cardiovascular problems with disopyramide.
    Warrington SJ; Hamer J
    Postgrad Med J; 1980 Apr; 56(654):229-33. PubMed ID: 7433320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular fibrillation during disopyramide treatment].
    Edhag O; Forssell G; Schenck-Gustafsson K
    Lakartidningen; 1981 Oct; 78(41):3597-600. PubMed ID: 7321703
    [No Abstract]   [Full Text] [Related]  

  • 17. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 18. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
    LaBarre A; Strauss HC; Scheinman MM; Evans GT; Bashore T; Tiedeman JS; Wallace AG
    Circulation; 1979 Feb; 59(2):226-35. PubMed ID: 758990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.